Erin Curley, MBA

Vice President of Business Development
International Genomics Consortium

Erin Curley is Vice President of Business Development for the International Genomics Consortium (IGC). In her current role, she oversees IGC’s national, scalable network of hospitals that delivers pristine cancer samples and patient clinical outcome data collected under strict quality control standards for genomic analysis for national research projects, including IGC’s Expression Project for Oncology (expO) and The Cancer Genome Atlas (TCGA) project.  She is also responsible for the strategic and financial evaluation of new projects and was part of the leadership team responsible for developing the Molecular Profiling Institute, a spin-off of the IGC.

In addition to her experience at the IGC, Ms. Curley has several years of experience working in the health care industry in various business roles. Most recently, she was the Director of Marketing for MedTrust Online, LLC, an oncology-focused web portal for physicians. She also has worked at the Translational Genomics Research Institute (TGen) where she was the Manager of Strategic Planning and at the Boston Consulting Group where she completed a variety of engagements in the pharmaceutical and biotechnology industries. Prior to attending business school, Ms. Curley worked at Eli Lilly & Company in their U.S. Managed Care and International Business Divisions.

Ms. Curley received her Master of Business Administration from the Fuqua School of Business at Duke University with a concentration in Health Sector Management. She graduated summa cum laude from DePauw University where she received a bachelor’s degree in chemistry.